Stabilized pharmaceutical peptide compositions
US5482931A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | Jun 29, 1993 |
| Grant date | Jan 9, 1996 |
| Priority date | — |
| Expiry date | Jun 29, 2013 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/095
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed is a stabilized aqueous composition for administration to a patient comprising a biologically active peptide, a buffer, a quaternary amine-type preservative or disinfectant, and an osmotic pressure-controlling agent, which composition can be stored and used at room temperature. The buffer stabilizes the pH of the composition between about 4 and 6. The preferred buffer contains citrate and/or phosphate, and the preferred preservative or disinfectant is benzalkonium chloride. The composition protects the peptide contained therein from adhering to container surfaces, particularly in containers made of polymeric materials.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.